Carlos Balmaceda Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Carlos Balmaceda's research focuses on health economics, public health, and disease burden estimation, particularly within the Chilean context. His work examines the economic impact and quality of life associated with various health conditions, including chronic musculoskeletal disorders and type 2 diabetes mellitus. Balmaceda has investigated the demand for palliative care in non-oncologic patients and analyzed the socioeconomic distribution of life expectancy and healthy life expectancy in Chile. He also conducts economic evaluations of treatments for conditions such as multiple sclerosis. His publications include a randomized phase II clinical trial on convalescent plasma for COVID-19. Balmaceda's scholarship metrics include an h-index of 12, with 75 total publications and 559 total citations.
Metrics
- h-index: 12
- Publications: 75
- Citations: 563
Selected Publications
-
High-level production of antibacterial pentacyclic triterpenoids from hairy root cultures of Bixa orellana via abiotic elicitation (2026)
-
Enhanced Production of Anti-Inflammatory and Antibacterial Prenylated Isoflavonoids in Pigeon Pea (<i>Cajanus cajan</i>) Hairy Root Cultures (2025)
Collaboration Network
Top Collaborators
- Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile
- Cost analysis of chronic pain due to musculoskeletal disorders in Chile
- Estimation of the demand for palliative care in non-oncologic patients in Chile
- Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis
- The socioeconomic distribution of life expectancy and healthy life expectancy in Chile
Showing 5 of 14 shared publications
- Estimation of the demand for palliative care in non-oncologic patients in Chile
- Analisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto)
- El costo esperado de cáncer en Chile
- EE492 Cost-Effectiveness of Dabigatran for Thromboembolic Events Prevention in Atrial Fibrillation Patients
- EE264 Predictions on the Health and Economic Effects for the Chilean Population With Type 2 Diabetes Mellitus Recently Diagnosed
Showing 5 of 11 shared publications
- Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile
- Cost analysis of chronic pain due to musculoskeletal disorders in Chile
- The socioeconomic distribution of life expectancy and healthy life expectancy in Chile
- Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile
- El costo esperado de cáncer en Chile
Showing 5 of 10 shared publications
- POSC151 Cost-Effectiveness Analysis of Ribociclib in Ecuadorian Women with Advanced Breast Cancer
- EE492 Cost-Effectiveness of Dabigatran for Thromboembolic Events Prevention in Atrial Fibrillation Patients
- EE264 Predictions on the Health and Economic Effects for the Chilean Population With Type 2 Diabetes Mellitus Recently Diagnosed
- EE369 Cost-Effectiveness Analysis of Drug Therapies for Diabetes Mellitus Type 2 in Chile
- EE300 Public Health Impact of Nirsevimab for RSV Prophylaxis in Infants: Insights From the Paraguayan Healthcare System
Showing 5 of 6 shared publications
- Fragmentation of Health Benefits Plans in Chile: Findings from a comparative policy analysis and implications for advancing Universal Health Coverage
- Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile
- <p>Estimation of age-specific prevalence of HPV genotypes.</p>
- <p>Estimation of histological lesions by genotype and age.</p>
- Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile
- Cost analysis of chronic pain due to musculoskeletal disorders in Chile
- Different Alternatives to Assess the Burden of Disease Using Attributable Fraction on a Disability Variable: The Case of Pain and Chronic Musculoskeletal Disorders in Chile
- Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile
- Cost analysis of chronic pain due to musculoskeletal disorders in Chile
- Different Alternatives to Assess the Burden of Disease Using Attributable Fraction on a Disability Variable: The Case of Pain and Chronic Musculoskeletal Disorders in Chile
- Cost analysis of chronic pain due to musculoskeletal disorders in Chile
- Analisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto)
- Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile
- EE369 Cost-Effectiveness Analysis of Drug Therapies for Diabetes Mellitus Type 2 in Chile
- EE471 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Costa Rica from the Public Health System Perspective
- EE15 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Uruguay from the Public Health System Perspective
- EE471 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Costa Rica from the Public Health System Perspective
- EE15 Cost-Effectiveness Evaluation of Human Papilloma Virus Test in Comparison with Cytology in Uruguay from the Public Health System Perspective
- Cost-effectiveness analysis of ribociclib versus palbociclib as a first line theraphy in HR+/HER2- advanced breast cancer: evidence from the Chilean public health system
- Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile
- <p>Estimation of age-specific prevalence of HPV genotypes.</p>
- <p>Estimation of histological lesions by genotype and age.</p>
- Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile
- <p>Estimation of age-specific prevalence of HPV genotypes.</p>
- <p>Estimation of histological lesions by genotype and age.</p>
- Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile
- <p>Estimation of age-specific prevalence of HPV genotypes.</p>
- <p>Estimation of histological lesions by genotype and age.</p>
- Different Alternatives to Assess the Burden of Disease Using Attributable Fraction on a Disability Variable: The Case of Pain and Chronic Musculoskeletal Disorders in Chile
- Medication review with follow-up for cardiovascular outcomes: a trial based cost–utility analysis
- Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
- Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study
Similar Researchers
Based on overlapping research topics